Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
Stopped The trial was stopped earlier than planned after an ad hoc interim analysis
Conditions
Interventions
- DIAGNOSTIC_TEST: Ultra-rapid molecular point-of-care testing
Sponsor
Haukeland University Hospital
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]